Montenegro vs Saint Kitts and Nevis: Prevalence of hypertension
Montenegro
45.1%
in 2019
Saint Kitts and Nevis
45.1%
in 2019
Montenegro rank
24th
Saint Kitts and Nevis rank
24th
Prevalence of hypertension over time
- Montenegro
- Saint Kitts and Nevis
How they compare
Montenegro currently reports 45.1% against 45.1% in Saint Kitts and Nevis, a difference of 0.0%.
The two have swapped places 1 time across 30 shared years of data; in 1990 it was Montenegro ahead.
Montenegro ranks 24th and Saint Kitts and Nevis ranks 24th of 192 countries.
Montenegro has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Montenegro | Saint Kitts and Nevis | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 46.2% | 40.1% | 6.1% | Montenegro |
| 2000s | 44.9% | 43.1% | 1.7% | Montenegro |
| 2010s | 45.1% | 45.0% | 0.1% | Montenegro |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hypertension, Montenegro or Saint Kitts and Nevis?
- Montenegro, at 45.1% against 45.1% in Saint Kitts and Nevis as of 2019.
- What is the difference in prevalence of hypertension between Montenegro and Saint Kitts and Nevis?
- 0.0%, with Montenegro ahead.
- How many years of comparable data are there for Montenegro and Saint Kitts and Nevis?
- 30 years are reported by both, from 1990 to 2019.
- How do Montenegro and Saint Kitts and Nevis rank globally for prevalence of hypertension?
- Montenegro ranks 24th and Saint Kitts and Nevis ranks 24th of 192 countries.
- Where does this data come from?
- World Health Organization's Global Health Observatory Data Repository, published as Prevalence of hypertension (% of adults ages 30-79). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Prevalence of hypertension is the percentage of adults ages 30-79 with hypertension (defined as having systolic blood pressure =140 mmHg, diastolic blood pressure =90 mmHg, or taking medication for hypertension). The data is age-standardized.